Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.

Saved in:
Bibliographic Details
Title: Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.
Authors: Burns LJ; Department of Medicine, University of Minnesota, Minneapolis 55455, USA. burns019@tc.umn.edu, Weisdorf DJ, DeFor TE, Repka TL, Ogle KM, Hummer C, Miller JS
Source: Experimental hematology [Exp Hematol] 2000 Jan; Vol. 28 (1), pp. 96-103.
Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print Cited Medium: Print ISSN: 0301-472X (Print) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0301-472X
DOI:10.1016/s0301-472x(99)00129-0